Showing 101 - 120 results of 345 for search '"Alzheimer disease"', query time: 0.08s Refine Results
  1. 101

    A Middle-Aged Woman with Logopenic Progressive Aphasia as a Precursor of Alzheimer's Disease: Case Report and Review of the Literature by Stephanie M. Awad, Amer M. Awad

    Published 2011-01-01
    “…The logopenic variant is the least common one and is closely related to Alzheimer's disease in comparison to the other two variants that are closely related to frontotemporal dementia. …”
    Get full text
    Article
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108

    Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease by Susmita Sil, Tusharkanti Ghosh

    Published 2016-01-01
    “…The anxiety status is changed along with memory impairments in intracerebroventricular colchicine injected rat model of Alzheimer Disease (cAD) due to neurodegeneration, which has been indicated to be mediated by inflammation. …”
    Get full text
    Article
  9. 109

    The impact of apolipoprotein E, type ∊4 allele on Alzheimer's disease pathological biomarkers: a comprehensive post-mortem pilot-analysis. by Ziyu Wan, Tao Ma

    Published 2025-01-01
    “…The apolipoprotein E type ∊4 allele (ApoE4) is known as the strongest genetic risk factor for Alzheimer's Disease (AD). Meanwhile, many aspects of its impact on AD pathology remain underexplored. …”
    Get full text
    Article
  10. 110
  11. 111
  12. 112

    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees. by Kin Wah Fung, Fitsum Baye, Seo H Baik, Clement J McDonald

    Published 2024-01-01
    “…For Parkinson's disease, terazosin was associated with 26% risk reduction (HR 0.74, 95%CI 0.66-0.83), and doxazosin with 21% risk reduction (HR 0.79, 95%CI 0.72-0.88). For Alzheimer's disease, terazosin was associated with 27% risk reduction (HR 0.73, 95%CI 0.65-0.82), and doxazosin with 16% risk reduction (HR 0.84, 95%CI 0.76-0.92). …”
    Get full text
    Article
  13. 113

    Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images by Ting Shen MsD, Jiehui Jiang PhD, Jiaying Lu MD, Min Wang MsD, Chuantao Zuo MD, PhD, Zhihua Yu, Zhuangzhi Yan PhD

    Published 2019-09-01
    “…Objective: Accurate diagnosis of early Alzheimer disease (AD) plays a critical role in preventing the progression of memory impairment. …”
    Get full text
    Article
  14. 114
  15. 115

    Application of Low Intensity Ultrasound in the Treatment of Alzheimer’s Disease by Hong Fei, Xu Fei

    Published 2025-03-01
    Subjects: “…|alzheimer's disease|pathology and pathogenesis|low intensity ultrasound…”
    Get full text
    Article
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120

    Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors. by Fatima Zahra Guerguer, Bouchra Rossafi, Oussama Abchir, Yasir S Raouf, Dhabya Bakhit Albalushi, Abdelouahid Samadi, Samir Chtita

    Published 2025-01-01
    “…Cognitive dysfunction in Alzheimer's disease results from a complex interplay of various pathological processes, including the dysregulation of key enzymes such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidase B (MAO-B). …”
    Get full text
    Article